The characteristics of the "ideal" pharmacotherapeutic agent for managing the symptoms of seasonal allergic rhinitis and the advantages and disadvantages of the pharmacotherapeutic agents that are currently available are reviewed. Decongestants, mast cell stabilizers, anticholinergics, intranasal steroids, and oral antihistamines and their place in the therapeutic armamentarium of the clinician are discussed.